Twist Bioscience Q3 Earnings Call Highlights
Twist Bioscience reported a 23% year-over-year revenue increase to $118.4 million for its fiscal third quarter. This marks the 14th consecutive quarter of growth for the synthetic biology company, demonstrating sustained expansion in its operations.
Key takeaways
- Revenue grew 23% to $118.4 million
- Achieved 14 consecutive quarters of growth
- Synthetic biology sector shows strong financial performance
- Indicates increasing investment in biotech infrastructure
Why it matters
This sustained growth in synthetic biology could lead to new AI-driven tools for biological data analysis and creation. Businesses leveraging AI for research and development may see expanded capabilities for drug discovery and material science.
Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
- RecallRecall is an AI video tool that helps users summarize and repurpose long-form video content into short-form clips, scripts, storyboards, and captions.
- KrispCallKrispCall is a cloud telephony system that integrates AI for intelligent call management features. It offers call recording, analytics, and virtual numbers, enhancing communication for businesses of all sizes.
- Calligrapher AICalligrapher AI transforms digital text into realistic, customizable handwriting, ideal for individuals and teams needing to personalize communications or create unique visual content without manual effort.



